Home > List All Publishers > Greystone Research Associates

Greystone Research Associates

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and reach their financial targets.

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.

List of reports from Greystone Research Associates

Injectable Drug Delivery to 2016 Drugs, Devices, Targets, Therapeutics and Forecasts 9/1/2012 \| published by: Greystone Research Associates ... levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges ... \| more... Search inside this report	$4,850.00
Integrated Safety Syringes to 2016 5/1/2012 \| published by: Greystone Research Associates ... for a sharps disposal step. Safety syringes address caregiver preferences and mitigate the cost premium associated with retractable models. While more than fifty companies compete in the safety syringe sector, only a handful companies manufacture ... \| more... Search inside this report	$2,850.00
Prefilled Syringes to 2016 4/1/2012 \| published by: Greystone Research Associates ... commercially. For Fill-and-Finish contractors, market proximity is an important competitive factor, and the past twelve months has seen major prefilled syringe CMOs expanding their operations in regional markets, particularly in North America. This report analyzes ... \| more... Search inside this report	$3,850.00
Needle Array Drug Delivery Systems 2/1/2012 \| published by: Greystone Research Associates ... and by the need for safer, more reliable drug products that improve compliance. For drugs designed to be delivered across the skin, needle arrays are viewed as an approach that addresses these key healthcare objectives. ... \| more... Search inside this report	$2,850.00
Drug Reconstitution at the Point-of-Care 1/1/2012 \| published by: Greystone Research Associates ... behind the innovative approaches that address the growing need for packaging and delivering lyophilized drugs for injection. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and ... \| more... Search inside this report	$3,850.00
Drug Self-Administration Markets to 2016 1/1/2012 \| published by: Greystone Research Associates ... new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery ... \| more... Search inside this report	$4,850.00
Active Transdermal Delivery Systems 10/15/2011 \| published by: Greystone Research Associates ... and business strategies Charts product sales data, market share, and forecasts to 2015 Profiles active transdermal delivery companies, their product development activities, business strategies, and corporate alliances and affiliations Assesses the importance of pharma-device alliances ... \| more... Search inside this report	$2,850.00
Microneedle Drug Delivery 5/1/2011 \| published by: Greystone Research Associates ... well as for integration with other miniaturized biochemical analysis systems. The needles are enabling for the manipulation of micro volumes of samples as well as for parallel distribution of samples or reagents on a close ... \| more... Search inside this report	$2,850.00
Drug Cartridge-based Syringes & Injectors 4/1/2011 \| published by: Greystone Research Associates ... and injectors have evolved considerable to address the changing demands of clinicians and their patients. In particular, the appearance and refinement of disposable drug cartridges has created unique opportunities for developers of injectable drugs. Prefilled ... \| more... Search inside this report	$3,850.00
Prefilled Syringes 4/1/2011 \| published by: Greystone Research Associates ... commercially. For Fill-and-Finish contractors, market proximity is an important competitive factor, and the past twelve months has seen major prefilled syringe CMOs expanding their operations in regional markets, particularly in North America. This report analyzes ... \| more... Search inside this report	$3,850.00
Dry Powder Inhalation 2/1/2011 \| published by: Greystone Research Associates ... therapies is focused on chronic diseases and refractory conditions - aliments that require frequent drug administration for a protracted period of time. While several approaches for delivering active substances to, and systematically via, the lungs ... \| more... Search inside this report	$3,850.00
Drug Solubility Technology and Platforms 1/1/2011 \| published by: Greystone Research Associates ... drug development. This impact extends beyond potential future drug therapeutics, affecting current reformulation strategies as well. As large-molecule therapeutics increase in number and as a percentage of all drug discoveries, the economic scales will tip ... \| more... Search inside this report	$3,850.00
Point-of-Delivery Drug Reconstitution Systems 1/1/2011 \| published by: Greystone Research Associates ... the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed - a distribution strategy referred to as the ‘Cold Chain’. Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins ... \| more... Search inside this report	$3,850.00
Autoinjectors 1/1/2011 \| published by: Greystone Research Associates ... recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to ... \| more... Search inside this report	$2,850.00
Delivering Drugs by Inhalation 12/1/2010 \| published by: Greystone Research Associates ... have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been ... \| more... Search inside this report	$3,850.00
Transdermal Pain Management to 2015 Markets, Demand Factors, Opportunities and Forecasts 12/1/2010 \| published by: Greystone Research Associates ... quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to transdermal formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, transdermal delivery ... \| more... Search inside this report	$3,850.00
Therapeutic Proteins to 2014 11/15/2010 \| published by: Greystone Research Associates ... becomes critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs continue to be developed almost exclusively ... \| more... Search inside this report	$4,850.00
Pen Injectors 11/15/2010 \| published by: Greystone Research Associates ... syringes. Advances in synthetic materials and concurrent development partnerships between pen designers and drug developers are important factors in the growth of this segment. With detailed product summariess, industry data and forecasts, pen injector company ... \| more... Search inside this report	$3,850.00
Injectable Drug Delivery 11/1/2010 \| published by: Greystone Research Associates ... levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges ... \| more... Search inside this report	$3,850.00
Drug Self-Administration Markets to 2014 11/1/2010 \| published by: Greystone Research Associates ... new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery ... \| more... Search inside this report	$4,850.00
Noninvasive Glucose Monitors Technology, Devices and Commercialization Potential 11/1/2010 \| published by: Greystone Research Associates ... patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies into the hunt for less invasive and more user-friendly alternatives. Now the convergence of ... \| more... Search inside this report	$2,850.00
Wireless In-Patient Monitors & Monitoring Systems 8/15/2010 \| published by: Greystone Research Associates ... streamlining the management of patient care. Extending integration beyond the wired hospital LAN via wirelessly enabled devices is the next frontier. The availability of wireless patient monitors that can increase the efficiency of already-strained nursing ... \| more... Search inside this report	$2,850.00
Molecular Imaging Agents 7/15/2010 \| published by: Greystone Research Associates ... generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care. Targetable and activatable imaging agents are gaining interest for a wide range of ... \| more... Search inside this report	$3,850.00
Closed Drug Transfer for Oncology Therapeutics 6/15/2010 \| published by: Greystone Research Associates ... area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely ... \| more... Search inside this report	$2,850.00
Pulmonary Inhalers & Systemic Drug Delivery 5/15/2010 \| published by: Greystone Research Associates ... therapies is focused on chronic diseases and refractory conditions - aliments that require frequent drug administration for a protracted period of time. The role of device design and development in defining and driving emerging opportunities ... \| more... Search inside this report	$2,850.00

< prev 1 2 next >

Greystone Research Associates

List of reports from Greystone Research Associates

Research assistance

Join Alert Me now!